Hypoglycemia Risk in Type 2 Diabetes
EARN CME CREDIT FOR THIS CASE
How do you help your patient, a 48-year-old Hispanic man with hypertension, hyperlipidemia, and newly diagnosed type 2 diabetes manage his diabetes and avoid hypoglycemia? This interactive case study features current definitions of hypoglycemia, hypoglycemia unawareness, and hypoglycemia-associated autonomic failure while explaining the implications of hypoglycemia on both short- and long-term outcomes of Type 2 diabetes mellitus.
Respond to questions about key points in the patient's care and get expert opinion from Dr. Irl Hirsch, endocrinologist, and Dr. Doron Schneieder, internist.
Use our hypoglycemia risk calculator to help assess your own type 2 diabetes patients' risk of hypoglycemia.
In order to claim CME credit for this case, you will need to create an account at endocrine.org if you don’t already have one.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
This activity is supported by an educational grant from Novo Nordisk, Inc.
The following faculty reported relevant financial relationships: Irl Hirsch, MD: Consultant, Abbott, Becton Dickinson, Roche; Research Grant, Novo Nordisk. Doron Schneider, MD: Consultant, Janssen Pharmaceuticals, Inc., Lilly USA, LLC, Novo Nordisk Inc.
The following SPC Committee members reported relevant financial relationships: Guillermo Umpierrez, MD, CDE, Advisory Board and Consultant, Abbott, Boehringer Ingelheim, Merck, Novo Nordisk, Regeneron, Sanofi; Research Grant Support, Boehringer Ingelheim, Merck & Co., Novo Nordisk, Regeneron
Endocrine Society and Knighten Health staff associated with the development of content for this activity reported no relevant financial relationships.